Catalyst Wire Dossier Catalyst Wire Dossier

Lactobacillus casei DG–containing probiotic preparation

Lactobacillus casei DG · SOFAR S.p.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lactobacillus casei DG–containing probiotic preparation, covering 2014-12-02 to 2014-12-02. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy Evaluation of a Commercial Preparation Containing Lactobacillus Casei DG on the Reduction of the Painful Symptoms Related to the Irritable Bowel Syndrome (IBS). A Pilot Clinical Study [Phase 4]

See pricing